• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

下尿路症状、良性前列腺增生/良性前列腺肿大与勃起功能障碍:这些病症与血管功能障碍有关吗?

Lower urinary tract symptoms, benign prostatic hyperplasia/benign prostatic enlargement and erectile dysfunction: are these conditions related to vascular dysfunction?

作者信息

Shimizu Shogo, Tsounapi Panagiota, Shimizu Takahiro, Honda Masashi, Inoue Keiji, Dimitriadis Fotios, Saito Motoaki

机构信息

Department of Pharmacology, Kochi Medical School, Kochi University, Nankoku, Japan.

出版信息

Int J Urol. 2014 Sep;21(9):856-64. doi: 10.1111/iju.12501. Epub 2014 Jun 15.

DOI:10.1111/iju.12501
PMID:24930630
Abstract

Although the pathogenesis of lower urinary tract symptoms, benign prostatic hyperplasia/benign prostatic enlargement and erectile dysfunction is poorly understood and thought to be multifactorial, it has been traditionally recognized that these conditions increase with age. There is increasing evidence that there is an association between cardiovascular disease and lower urinary tract symptoms as well as benign prostatic hyperplasia/benign prostatic enlargement and erectile dysfunction in elderly patients. Age might activate systemic vascular risk factors, resulting in disturbed blood flow. Hypertension, diabetes, hyperlipidemia and atherosclerosis are also linked to the etiology of lower urinary tract symptoms, benign prostatic hyperplasia/benign prostatic enlargement and erectile dysfunction. In the present review, we discuss the relationship between decreased pelvic blood flow and lower urinary tract symptoms, benign prostatic hyperplasia/benign prostatic enlargement and erectile dysfunction. Furthermore, we suggest possible common mechanisms underlining these urological conditions.

摘要

尽管下尿路症状、良性前列腺增生/前列腺肿大和勃起功能障碍的发病机制尚不清楚,且被认为是多因素的,但传统上人们已经认识到,这些病症会随着年龄的增长而增加。越来越多的证据表明,老年患者心血管疾病与下尿路症状以及良性前列腺增生/前列腺肿大和勃起功能障碍之间存在关联。年龄可能会激活全身血管危险因素,导致血流紊乱。高血压、糖尿病、高脂血症和动脉粥样硬化也与下尿路症状、良性前列腺增生/前列腺肿大和勃起功能障碍的病因有关。在本综述中,我们讨论了盆腔血流减少与下尿路症状、良性前列腺增生/前列腺肿大和勃起功能障碍之间的关系。此外,我们提出了这些泌尿系统疾病可能的共同潜在机制。

相似文献

1
Lower urinary tract symptoms, benign prostatic hyperplasia/benign prostatic enlargement and erectile dysfunction: are these conditions related to vascular dysfunction?下尿路症状、良性前列腺增生/良性前列腺肿大与勃起功能障碍:这些病症与血管功能障碍有关吗?
Int J Urol. 2014 Sep;21(9):856-64. doi: 10.1111/iju.12501. Epub 2014 Jun 15.
2
A new experimental rat model of erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: the testosterone-supplemented spontaneously hypertensive rat.一种新型与良性前列腺增生相关的勃起功能障碍和下尿路症状的实验性大鼠模型:补充睾酮的自发性高血压大鼠。
BJU Int. 2012 Nov;110(9):1352-8. doi: 10.1111/j.1464-410X.2012.11085.x. Epub 2012 Mar 27.
3
Direct effects of tadalafil on lower urinary tract symptoms versus indirect effects mediated through erectile dysfunction symptom improvement: integrated data analyses from 4 placebo controlled clinical studies.他达拉非对下尿路症状的直接作用与通过改善勃起功能障碍症状介导的间接作用:4 项安慰剂对照临床研究的综合数据分析。
J Urol. 2014 Feb;191(2):405-11. doi: 10.1016/j.juro.2013.09.057. Epub 2013 Oct 1.
4
Efficacy and safety of the coadministration of tadalafil once daily with finasteride for 6 months in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia.每日一次他达拉非联合非那雄胺治疗良性前列腺增生所致下尿路症状和前列腺增生的 6 个月疗效和安全性。
J Urol. 2014 Mar;191(3):727-33. doi: 10.1016/j.juro.2013.09.059. Epub 2013 Oct 2.
5
Lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction: from physiology to clinical aspects.下尿路症状/良性前列腺增生与勃起功能障碍:从生理学到临床层面
Aging Male. 2018 Dec;21(4):261-271. doi: 10.1080/13685538.2018.1430758. Epub 2018 Jan 27.
6
[Relationship between lower urinary tract symptoms in men and erectile dysfunction].男性下尿路症状与勃起功能障碍之间的关系
Semergen. 2016 Apr;42(3):164-71. doi: 10.1016/j.semerg.2015.07.005. Epub 2015 Dec 10.
7
The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study.前列腺尿道提升术治疗良性前列腺增生引起的前列腺增大相关下尿路症状:LIFT 研究。
J Urol. 2013 Dec;190(6):2161-7. doi: 10.1016/j.juro.2013.05.116. Epub 2013 Jun 11.
8
Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems.良性前列腺增生和下尿路症状的可改变风险因素:老问题的新方法
J Urol. 2007 Aug;178(2):395-401. doi: 10.1016/j.juro.2007.03.103. Epub 2007 Jun 11.
9
Impact of phytotherapy on utility scores for 5 benign prostatic hyperplasia/lower urinary tract symptoms health states.植物疗法对5种良性前列腺增生/下尿路症状健康状态效用评分的影响。
J Urol. 2008 Jan;179(1):220-5. doi: 10.1016/j.juro.2007.08.152. Epub 2007 Nov 14.
10
Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia.良性前列腺增生所致下尿路症状与性功能障碍关系的批判性分析。
Eur Urol. 2011 Oct;60(4):809-25. doi: 10.1016/j.eururo.2011.06.037. Epub 2011 Jun 29.

引用本文的文献

1
Association of detrusor underactivity with aging and metabolic syndrome: suggestions from animal models.逼尿肌活动低下与衰老和代谢综合征的关系:来自动物模型的提示。
J Smooth Muscle Res. 2024;60:23-30. doi: 10.1540/jsmr.60.23.
2
Insights into the associative role of hypertension and angiotensin II receptor in lower urinary tract dysfunction.探讨高血压和血管紧张素Ⅱ受体在下尿路功能障碍中的关联作用。
Hypertens Res. 2024 Apr;47(4):987-997. doi: 10.1038/s41440-024-01597-8. Epub 2024 Feb 14.
3
Bunge Ameliorates Benign Prostatic Hyperplasia through Regulation of Oxidative Stress via Nrf-2/HO-1 Activation.
Bunge 通过激活 Nrf-2/HO-1 来调节氧化应激改善良性前列腺增生。
J Microbiol Biotechnol. 2024 May 28;34(5):1059-1072. doi: 10.4014/jmb.2308.08053. Epub 2023 Oct 31.
4
The Etiology and Pathophysiology Genesis of Benign Prostatic Hyperplasia and Prostate Cancer: A New Perspective.良性前列腺增生和前列腺癌的病因学与病理生理学起源:一个新视角。
Medicines (Basel). 2021 Jun 11;8(6):30. doi: 10.3390/medicines8060030.
5
Single nucleotide polymorphisms (SNPs) in prostate cancer: its implications in diagnostics and therapeutics.前列腺癌中的单核苷酸多态性(SNPs):其在诊断和治疗中的意义。
Am J Transl Res. 2021 Apr 15;13(4):3868-3889. eCollection 2021.
6
The effectiveness and safety of moxibustion for treating benign prostatic hyperplasia: A protocol for systematic review and meta-analysis.艾灸治疗良性前列腺增生的有效性和安全性:系统评价与荟萃分析方案
Medicine (Baltimore). 2020 Sep 4;99(36):e22006. doi: 10.1097/MD.0000000000022006.
7
Hydrogen sulfide-induced relaxation of the bladder is attenuated in spontaneously hypertensive rats.硫化氢诱导的膀胱松弛在自发性高血压大鼠中减弱。
Int Urol Nephrol. 2019 Sep;51(9):1507-1515. doi: 10.1007/s11255-019-02222-1. Epub 2019 Jul 5.
8
High glucose induces the proliferation of prostatic cells via downregulating MRE11.高葡萄糖通过下调 MRE11 诱导前列腺细胞增殖。
Int J Mol Med. 2018 Jun;41(6):3105-3114. doi: 10.3892/ijmm.2018.3549. Epub 2018 Mar 7.
9
Report and Research Agenda of the American Geriatrics Society and National Institute on Aging Bedside-to-Bench Conference on Urinary Incontinence in Older Adults: A Translational Research Agenda for a Complex Geriatric Syndrome.美国老年医学学会和美国国家老龄化研究所关于老年人尿失禁的床边到实验室会议的报告和研究议程:一个复杂老年综合征的转化研究议程。
J Am Geriatr Soc. 2018 Apr;66(4):773-782. doi: 10.1111/jgs.15157. Epub 2017 Dec 4.
10
Positive Response to Thermobalancing Therapy Enabled by Therapeutic Device in Men with Non-Malignant Prostate Diseases: BPH and Chronic Prostatitis.治疗设备实现的热平衡疗法对患有非恶性前列腺疾病(良性前列腺增生和慢性前列腺炎)的男性产生积极反应。
Diseases. 2016 Apr 18;4(2):18. doi: 10.3390/diseases4020018.